Anyelin Almanzar

Papers

Total Citations

H-Index

About

Anyelin Almanzar is a clinical researcher whose work focuses on improving outcomes for colorectal cancer patients through the optimization of adjuvant chemotherapy (AC) delivery. Her research addresses a critical gap in oncology: understanding the real-world barriers that prevent patients from receiving timely, life-saving treatment. In her most cited study, "Predictors of Timely Initiation and Completion of Adjuvant Chemotherapy in Stage II/III Colorectal Adenocarcinoma," Almanzar investigates the patient, clinical, and systemic factors that influence whether AC is started within the recommended 6-8 week window after surgery—a period strongly associated with improved survival. By identifying these predictors, her work provides actionable insights for clinicians and healthcare systems to reduce disparities and improve adherence to evidence-based protocols. While her citation count is currently modest, this foundational research has immediate clinical relevance and lays the groundwork for future interventions aimed at closing the treatment gap. Almanzar’s dedication to translating clinical trial evidence into practical, patient-centered care marks her as a rising voice in surgical oncology and health services research.